Vivos Therapeutics, Inc. Goodwill
Vivos Therapeutics, Inc. (VVOS) had Goodwill of $8.57 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-14
- 2026-06-30: Goodwill $8.57M.
- 2026-03-31: Goodwill $8.57M.
- 2025-12-31: Goodwill $8.57M.
- 2025-09-30: Goodwill $8.45M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $8.57M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $8.57M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $8.57M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.45M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $8.45M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $2.84M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.84M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $2.84M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.84M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.84M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.84M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.84M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.84M 10-Q · filed 2023-08-16 | |
| 2023-03-31 | $2.84M 10-Q · filed 2023-06-08 | |
| 2022-12-31 | $2.84M 10-K/A · filed 2024-07-30 | |
| 2022-09-30 | $2.84M 10-Q · filed 2022-12-20 | |
| 2022-06-30 | $2.84M 10-Q · filed 2022-12-20 | |
| 2022-03-31 | $2.84M 10-Q/A · filed 2022-11-25 | |
| 2021-12-31 | $2.84M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $2.84M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.84M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.67M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.67M 10-K · filed 2022-03-31 | $2.67M 10-K · filed 2021-03-25 |
| 2019-12-31 | $2.67M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |